Meningococcal B disease: assessment and management
CPD Previous     Next

Meningococcal B disease: assessment and management

Adrienne Willcox Nurse director, A Talent 4 Health Limited, Cheltenham

Serogroup B meningococcal disease is the last main cause of bacterial meningitis and septicaemia in the UK. There is currently no vaccine against this serogroup. This article outlines the nature of meningococcal disease and highlights recent guidance from the National Institute for Health and Clinical Excellence on recognising and managing the disease in primary and secondary care. An update on progress towards a preventive vaccine is also discussed.

Nursing Standard. 26, 26,50-55. doi: 10.7748/ns2012.02.26.26.50.c8971

Peer review

This article has been subject to double blind peer review